Skip to main content
RAPS Convergence 2025 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Invitation Only
Invitation Only
Separate Ticket or Advanced Registration Required
Separate Ticket or Advanced Registration Required
Repeat Solutions Circle
Repeat Solutions Circle
Evaluation Video ViewAttendees 14

Pharmaceuticals (includes Biologics & Drugs)

Navigating the Future of mRNA Therapeutics-Exploration of Draft Guidelines, Industry Challenges, and Expert Insights

Wednesday, October 8, 2025
4:30 PM - 5:30 PM EST
Location/Room: 403
The development of mRNA therapeutics represents one of the most groundbreaking innovations in modern medicine. Traditionally, drug development has focused on small molecules and biologics, but mRNA medicines are changing the landscape by directly instructing cells to produce proteins.
This session plans to explore the science behind mRNA medicines, the current applications, the challenges faced, and the potential for future breakthroughs. It will also delve into topics to discuss rapid development and success of mRNA COVID-19 vaccines, Alliance for mRNA Medicines (AMM), and key regulatory considerations for the quality, safety, and efficacy of mRNA medicines.

Learning Objectives:

  • Investigate how mRNA therapeutics work at the cellular level, including their delivery to cells, translation into proteins, therapeutic effects, specifically the use of mRNA in vaccines (e.g., COVID-19), cancer immunotherapy, and genetic disease treatments.
  • Evaluate issues related to vaccine distribution, stability, immune responses, and scalability and learn about the new guidelines and regulations for mRNA therapeutics.
  • Examine the possibilities for expanding mRNA applications to new therapeutic areas, including rare diseases, autoimmune disorders, and neurodegenerative diseases.